GSGCX
Price
$45.52
Change
+$0.33 (+0.73%)
Updated
Jul 3 closing price
Net Assets
410.88M
VIVIX
Price
$70.10
Change
+$0.40 (+0.57%)
Updated
Jul 3 closing price
Net Assets
188.77B
Interact to see
Advertisement

GSGCX vs VIVIX

Header iconGSGCX vs VIVIX Comparison
Open Charts GSGCX vs VIVIXBanner chart's image
Goldman Sachs Equity Income C
Price$45.52
Change+$0.33 (+0.73%)
VolumeN/A
Net Assets410.88M
Vanguard Value Index I
Price$70.10
Change+$0.40 (+0.57%)
VolumeN/A
Net Assets188.77B
GSGCX vs VIVIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GSGCX vs. VIVIX commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSGCX is a Buy and VIVIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 189B vs. GSGCX (411M). VIVIX pays higher dividends than GSGCX: VIVIX (2.19) vs GSGCX (0.63). GSGCX was incepted earlier than VIVIX: GSGCX (28 years) vs VIVIX (27 years). GSGCX (1.95) is less costly to investors than VIVIX (0.04). GSGCX is a more actively managed with annual turnover of: 31.00 vs. VIVIX (9.00). GSGCX has a lower initial minimum investment than VIVIX: GSGCX (1000) vs VIVIX (5000000). VIVIX annual gain was more profitable for investors over the last year : 11.41 vs. GSGCX (4.83). VIVIX return over 5 years is better than : 79.11 vs. GSGCX (41.60).
GSGCXVIVIXGSGCX / VIVIX
Total Expense Ratio1.750.044,375%
Annual Report Gross Expense Ratio1.950.044,875%
Fund Existence28 years27 years-
Gain YTD6.1645.609110%
Front LoadN/AN/A-
Min. Initial Investment100050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets411M189B0%
Annual Yield % from dividends0.632.1929%
Returns for 1 year4.8311.4142%
Returns for 3 years19.2334.4056%
Returns for 5 years41.6079.1153%
Returns for 10 years56.56114.4549%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KB85.701.60
+1.90%
KB Financial Group
BNL16.340.14
+0.86%
Broadstone Net Lease
EYPT9.720.06
+0.62%
EyePoint Pharmaceuticals
ACTU6.59-0.15
-2.23%
Actuate Therapeutics Inc
SNSE9.03-0.24
-2.54%
Sensei Biotherapeutics Inc